José L. Cangiano

A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease

Carl J. Pepine, Eileen Handberg, Rhonda M. Cooper‐DeHoff et al. · JAMA · 2003 · 1.3K citations

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients

Wadi N. Suki, Raja I. Zabaneh, José L. Cangiano et al. · Kidney International · 2007 · 515 citations · Full text

Hemodialysis, Urology, Renal Function +8

Hypertension in End-Stage Renal Disease

Victor Vertes, José L. Cangiano, Leonard B. Berman et al. · New England Journal of Medicine · 1969 · 378 citations

Hypertension, Renal Pathology, Renal Inflammation +22

Oral Hypoxia–Inducible Factor Prolyl Hydroxylase Inhibitor Roxadustat (FG-4592) for the Treatment of Anemia in Patients with CKD

Robert Provenzano, Anatole Besarab, Chao Sun et al. · Clinical Journal of the American Society of Nephrology · 2016 · 290 citations · Full text